{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:17:05Z","timestamp":1785525425665,"version":"3.56.0"},"reference-count":81,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0165614","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T19:04:27Z","timestamp":1480619067000},"page":"e0165614","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cost-Effectiveness of Community-Based TB\/HIV Screening and Linkage to Care in Rural South Africa"],"prefix":"10.1371","volume":"11","author":[{"given":"Jennifer A.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheela V.","family":"Shenoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald H.","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. David","family":"Paltiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison P.","family":"Galvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"ref1","unstructured":"WHO. WHO Three I&apos;s Meeting. Intensified Case Finding (ICF), Isoniazid Preventive Therapy (IPT) and TB Infection Control (IC) for people living with HIV. Geneva, Switzerland: World Health Organization, 2008 2\u20134 April 2008. Report No."},{"key":"ref2","article-title":"Global Tuberculosis Report 2014","year":"2014"},{"key":"ref3","article-title":"National Tuberculosis Management Guidelines","year":"2014"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2458-5-130","article-title":"Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence","volume":"5","author":"CS Currie","year":"2005","journal-title":"BMC Public Health"},{"issue":"9 Suppl 1","key":"ref5","first-page":"S9","article-title":"Expanding the WHO tuberculosis control strategy: rethinking the role of active case-finding","volume":"2","author":"CJ Murray","year":"1998","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/S2352-3018(15)00016-8","article-title":"Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis","volume":"2","author":"JA Smith","year":"2015","journal-title":"Lancet HIV"},{"key":"ref7","article-title":"Identifying dynamic tuberculosis case-finding policies for HIV\/TB coepidemics","author":"R Yaesoubi","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"e85197","DOI":"10.1371\/journal.pone.0085197","article-title":"Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness","volume":"9","author":"IV Bassett","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"e0126267","DOI":"10.1371\/journal.pone.0126267","article-title":"Integrating Community-Based Interventions to Reverse the Convergent TB\/HIV Epidemics in Rural South Africa","volume":"10","author":"JA Gilbert","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"e54587","DOI":"10.1371\/journal.pone.0054587","article-title":"What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?","volume":"8","author":"A Pooran","year":"2013","journal-title":"PLoS One"},{"key":"ref11","unstructured":"WHO. WHO TB Burden Estimates. 2014."},{"key":"ref12","article-title":"Mid-year population estimates 2014","year":"2014"},{"issue":"9597","key":"ref13","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(07)61636-5","article-title":"Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study","volume":"370","author":"S Basu","year":"2007","journal-title":"Lancet"},{"issue":"14","key":"ref14","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1073\/pnas.140102797","article-title":"Criteria for the control of drug-resistant tuberculosis","volume":"97","author":"C Dye","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"18","key":"ref15","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1073\/pnas.0600349103","article-title":"Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations","volume":"103","author":"T Cohen","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nm1110","article-title":"Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness","volume":"10","author":"T Cohen","year":"2004","journal-title":"Nature medicine"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/thx.2003.011759","article-title":"Transmission of tuberculosis from smear negative patients: a molecular epidemiology study","volume":"59","author":"E Hernandez-Garduno","year":"2004","journal-title":"Thorax"},{"key":"ref18","unstructured":"WHO. Global Tuberculosis Report 2013. Geneva, Switzerland: 2013."},{"issue":"9407","key":"ref19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(04)15496-2","article-title":"Programmes and principles in treatment of multidrug-resistant tuberculosis","volume":"363","author":"JS Mukherjee","year":"2004","journal-title":"Lancet"},{"issue":"9144","key":"ref20","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(98)03199-7","article-title":"Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy","volume":"352","author":"C Dye","year":"1998","journal-title":"Lancet"},{"issue":"14","key":"ref21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1098\/rsif.2006.0193","article-title":"Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission","volume":"4","author":"T Cohen","year":"2007","journal-title":"Journal of the Royal Society, Interface \/ the Royal Society"},{"key":"ref22","unstructured":"Actuarial Society of South Africa. ASSA2008 Model. 2011."},{"key":"ref23","article-title":"Recommendations for a public health approach. 2010 revision","year":"2010"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00042560-199504000-00010","article-title":"CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis","volume":"8","author":"DJ Martin","year":"1995","journal-title":"Journal of acquired immune deficiency syndromes and human retrovirology: official publication of the International Retrovirology Association"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1473-3099(10)70093-1","article-title":"Effect of treating co-infections on HIV-1 viral load: a systematic review","volume":"10","author":"K Modjarrad","year":"2010","journal-title":"The Lancet infectious diseases"},{"issue":"9323","key":"ref26","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study","volume":"359","author":"M Badri","year":"2002","journal-title":"Lancet"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil","volume":"21","author":"JE Golub","year":"2007","journal-title":"AIDS"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccm.2009.08.010","article-title":"Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings","volume":"30","author":"SD Lawn","year":"2009","journal-title":"Clin Chest Med"},{"key":"ref29","unstructured":"Health Systems Trust. Bacteriologic Coverage Rate (%) South Africa2012 [7 April 2015]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/indicators.hst.org.za\/healthstats\/164\/data\" xlink:type=\"simple\">http:\/\/indicators.hst.org.za\/healthstats\/164\/data<\/ext-link>."},{"issue":"18","key":"ref30","doi-asserted-by":"crossref","first-page":"7672","DOI":"10.1073\/pnas.0812472106","article-title":"Averting epidemics of extensively drug-resistant tuberculosis","volume":"106","author":"S Basu","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref31","article-title":"Part III: culture","year":"1998"},{"issue":"32","key":"ref32","doi-asserted-by":"crossref","first-page":"11293","DOI":"10.1073\/pnas.0800965105","article-title":"Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing","volume":"105","author":"DW Dowdy","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref33","unstructured":"Republic of South Africa. Multi-Drug Resistant Tuberculosis. A Policy Framework on Decentralised and Deinstitutionalised Management for South Africa. 2011."},{"key":"ref34","unstructured":"Republic of South Africa. The South African Antiretroviral Treatment Guidelines. 2013."},{"issue":"7","key":"ref35","doi-asserted-by":"crossref","first-page":"e1001056","DOI":"10.1371\/journal.pmed.1001056","article-title":"Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review","volume":"8","author":"S Rosen","year":"2011","journal-title":"PLoS medicine"},{"issue":"Suppl 1","key":"ref36","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/01.aids.0000366081.91192.1c","article-title":"Who starts antiretroviral therapy in Durban, South Africa?\u2026 not everyone who should","volume":"24","author":"IV Bassett","year":"2010","journal-title":"AIDS"},{"issue":"Suppl 1","key":"ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3156.2010.02508.x","article-title":"Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007\u20132009: systematic review","volume":"15","author":"MP Fox","year":"2010","journal-title":"Tropical medicine & international health: TM & IH"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4102\/sajhivmed.v13i1.156","article-title":"Access to Antiretroviral Treatment in South Africa, 2004\u20132011","volume":"13","author":"LF Johnson","year":"2012","journal-title":"The Southern African Journal of HIV Medicine"},{"key":"ref39","article-title":"A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa","author":"TAS Group","year":"2015","journal-title":"N Engl J Med"},{"key":"ref40","article-title":"Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection","author":"ISS Group","year":"2015","journal-title":"N Engl J Med"},{"issue":"14","key":"ref41","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1073\/pnas.1317660111","article-title":"Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings","volume":"111","author":"RM Houben","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref42","article-title":"Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings","year":"2011"},{"key":"ref43","article-title":"WHO Policy on Collaborative TB\/HIV Activities: Guidelines for National Programmes and Other Stakeholders","year":"2012"},{"issue":"7","key":"ref44","doi-asserted-by":"crossref","first-page":"903","DOI":"10.5588\/ijtld.11.0722","article-title":"Survey of isoniazid preventive therapy in South Africa, 2011","volume":"16","author":"JC Chehab","year":"2012","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"3 (Suppl 1)","key":"ref45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7196\/SAMJ.7689","article-title":"Tuberculosis control in South Africa: Successes, challenges and recommendations","volume":"104","author":"GJ Churchyard","year":"2014","journal-title":"S Afr Med J"},{"key":"ref46","article-title":"Recommendation on 36 months of isoniazid preventive therapy to adults and adolescents living with HIV in resource-constrained and high TB- and HIV-prevalence settings: 2015 update","year":"2015"},{"issue":"5","key":"ref47","first-page":"652","article-title":"Primary and secondary tuberculosis preventive treatment in HIV clinics: simulating alternative strategies","volume":"13","author":"S Basu","year":"2009","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"e5602","DOI":"10.1371\/journal.pone.0005602","article-title":"Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV","volume":"4","author":"H Ayles","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"e1000391","DOI":"10.1371\/journal.pmed.1000391","article-title":"Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies","volume":"8","author":"H Getahun","year":"2011","journal-title":"PLoS medicine"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5588\/ijtld.11.0401","article-title":"Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa","volume":"16","author":"M Loveday","year":"2012","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"key":"ref51","first-page":"288","article-title":"Point-of-Care Rapid Tests for HIV Antibodies","volume":"27","author":"DM Branson","year":"2003","journal-title":"J Lab Med"},{"key":"ref52","article-title":"National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults","year":"2014"},{"issue":"7","key":"ref53","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1473-3099(10)70078-5","article-title":"Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources","volume":"10","author":"SD Lawn","year":"2010","journal-title":"The Lancet infectious diseases"},{"issue":"180","key":"ref54","doi-asserted-by":"crossref","first-page":"180ra49","DOI":"10.1126\/scitranslmed.3005260","article-title":"Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis","volume":"5","author":"HL Mills","year":"2013","journal-title":"Science translational medicine"},{"issue":"4","key":"ref55","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/cid\/cir406","article-title":"Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa","volume":"53","author":"KR Jacobson","year":"2011","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"ref56","article-title":"Macroeconomics and health: investing in health for economic development","year":"2001"},{"key":"ref57","unstructured":"World Bank. GDP per capita (current US$) 2013 [cited 2015 11 May 2015]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD\" xlink:type=\"simple\">http:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD<\/ext-link>."},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0272989X12458348","article-title":"Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6","volume":"32","author":"AH Briggs","year":"2012","journal-title":"Med Decis Making"},{"issue":"2 Suppl","key":"ref59","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1177\/0272989X98018002S09","article-title":"Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis","volume":"18","author":"AA Stinnett","year":"1998","journal-title":"Med Decis Making"},{"issue":"8","key":"ref60","doi-asserted-by":"crossref","first-page":"e0135048","DOI":"10.1371\/journal.pone.0135048","article-title":"A Cost-Effectiveness Analysis of a Home-Based HIV Counselling and Testing Intervention versus the Standard (Facility Based) HIV Testing Strategy in Rural South Africa","volume":"10","author":"H Tabana","year":"2015","journal-title":"PLoS One"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"19843","DOI":"10.7448\/IAS.18.1.19843","article-title":"Linkage to care following a home-based HIV counselling and testing intervention in rural South Africa","volume":"18","author":"R Naik","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12879-015-1053-2","article-title":"Home-based HIV testing for men preferred over clinic-based testing by pregnant women and their male partners, a nested cross-sectional study","volume":"15","author":"AO Osoti","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"8","key":"ref63","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/0956462415592789","article-title":"What motivates use of community-based human immunodeficiency virus testing in rural South Africa?","volume":"27","author":"D Upadhya","year":"2016","journal-title":"Int J STD AIDS"},{"issue":"a","key":"ref64","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12913-016-1627-8","article-title":"Impact of nurse-delivered community-based CD4 services on facilitating pre-ART care in rural South Africa","volume":"16","author":"T Kompala","year":"2016","journal-title":"BMC Health Serv Res"},{"issue":"9776","key":"ref65","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study","volume":"377","author":"CC Boehme","year":"2011","journal-title":"Lancet"},{"issue":"9547","key":"ref66","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"NR Gandhi","year":"2006","journal-title":"Lancet"},{"key":"ref67","article-title":"The KZN &quot;outbreak&quot;","year":"2006"},{"issue":"3","key":"ref68","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(09)70041-6","article-title":"Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis","volume":"9","author":"EW Orenstein","year":"2009","journal-title":"The Lancet infectious diseases"},{"issue":"1","key":"ref69","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1086\/653115","article-title":"Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis","volume":"51","author":"KR Jacobson","year":"2010","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"ref70","unstructured":"Health Systems Trust. Defaulter (interruption) rate (new Sm+ cases) (%) 2011 [cited 2015 21 April 2015]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/indicators.hst.org.za\/healthstats\/167\/data\" xlink:type=\"simple\">http:\/\/indicators.hst.org.za\/healthstats\/167\/data<\/ext-link>."},{"issue":"1","key":"ref71","first-page":"99","article-title":"Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa","volume":"12","author":"CK Mlambo","year":"2008","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"10","key":"ref72","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3201\/eid1710.100952","article-title":"Drug-Resistant tuberculosis, KwaZulu-Natal, South Africa, 2001\u20132007","volume":"17","author":"K Wallengren","year":"2011","journal-title":"Emerging infectious diseases"},{"issue":"11","key":"ref73","doi-asserted-by":"crossref","first-page":"e1001347","DOI":"10.1371\/journal.pmed.1001347","article-title":"Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB\/RIF: A Dynamic Simulation and Economic Evaluation","volume":"9","author":"NA Menzies","year":"2012","journal-title":"PLoS medicine"},{"key":"ref74","article-title":"South African Health Reveiw: Chapter 5\u2014Financing Antiretroviral Treatment and Primary Health Care Services","author":"S Cleary","year":"2005"},{"issue":"2","key":"ref75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/QAI.0b013e31814277c8","article-title":"Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department","volume":"46","author":"IV Bassett","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"ref76","doi-asserted-by":"crossref","first-page":"e30216","DOI":"10.1371\/journal.pone.0030216","article-title":"Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011\u20132050","volume":"7","author":"R Granich","year":"2012","journal-title":"PLoS One"},{"key":"ref77","article-title":"Cost-Effectiveness of Antiretroviral Treatment for HIV-Positive Adults in a South African Township","author":"S Cleary","year":"2004"},{"issue":"1","key":"ref78","first-page":"CD000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","author":"C Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"ref79","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.5588\/ijtld.13.0571","article-title":"Cost-effectiveness of the Three I&apos;s for HIV\/TB and ART to prevent TB among people living with HIV","volume":"18","author":"S Gupta","year":"2014","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"11","key":"ref80","doi-asserted-by":"crossref","first-page":"e80017","DOI":"10.1371\/journal.pone.0080017","article-title":"Linkage to HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa","volume":"8","author":"D Govindasamy","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"ref81","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/QAI.0b013e31829b567d","article-title":"High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa","volume":"64","author":"H van Rooyen","year":"2013","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0165614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:37:13Z","timestamp":1589020633000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0165614"}},"subtitle":[],"editor":[{"given":"Alan","family":"Landay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":81,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0165614","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}